FDA approved a reformulated COVID-19 vaccine targeting LP.8.1 for 2025–2026. Vaccine eligibility is now limited. California reports rising cases as pharmacies await updated vaccine guidance. With ...

Certain individuals with cancer were significantly more likely to survive if they received a COVID-19 mRNA vaccine, researchers at the University of Texas MD Anderson Cancer Center reported. This ...